Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Myosin IC anticorps (AA 765-1011)

MYO1C Reactivité: Humain WB, IHC, ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1078388
  • Antigène Voir toutes Myosin IC (MYO1C) Anticorps
    Myosin IC (MYO1C)
    Épitope
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 765-1011
    Reactivité
    • 18
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 18
    • 1
    Lapin
    Clonalité
    • 18
    • 1
    Polyclonal
    Conjugué
    • 14
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Myosin IC est non-conjugé
    Application
    • 17
    • 12
    • 9
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against MYO1C. It has been selected for its ability to recognize MYO1C in immunohistochemical staining and western blotting.
    Purification
    Antigen-specific affinity chromatography
    Immunogène
    MYO1C (Gln765-Asn1011)
    Isotype
    IgG
    Top Product
    Discover our top product MYO1C Anticorps primaire
  • Indications d'application
    • Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    4 °C
    Stockage commentaire
    Store at 2-8 °C for one month. Aliquot and store at -80 °C for 12 months.
    Date de péremption
    12 months
  • Antigène
    Myosin IC (MYO1C)
    Abstract
    MYO1C Produits
    Synonymes
    anticorps MMI-beta, anticorps MMIb, anticorps NMI, anticorps myr2, anticorps C80397, anticorps MYO1E, anticorps mm1beta, anticorps Myr2, anticorps mmib, anticorps myo1c, anticorps nm1, anticorps Myo1c, anticorps Myosin-Ic, anticorps MMI-beta-A, anticorps MMIb-A, anticorps DDBDRAFT_0202969, anticorps DDBDRAFT_0215355, anticorps DDB_0202969, anticorps DDB_0215355, anticorps 43CD, anticorps CG2146, anticorps Didum, anticorps DmV, anticorps Dmel\CG2146, anticorps M5, anticorps MYOV, anticorps Myo1C, anticorps Myo5, anticorps MyoV, anticorps MyoV43CD, anticorps NEST:bs14c05, anticorps NMC7, anticorps dmM5, anticorps myoV, anticorps soy, anticorps myosin IC, anticorps myosin 1C, anticorps myosin IC L homeolog, anticorps myosin Ic, paralog b, anticorps myosin Ic, paralog a, anticorps myosin IC S homeolog, anticorps class I myosin, anticorps dilute class unconventional myosin, anticorps MYO1C, anticorps Myo1c, anticorps myo1c.L, anticorps myo1cb, anticorps myo1c, anticorps myo1ca, anticorps myo1c.S, anticorps myoC, anticorps didum
    Sujet
    Alternative Names: MMI-beta, MMIb, NMI, myr2
    Pathways
    Platelet-derived growth Factor Receptor Signaling
Vous êtes ici:
Support technique